US EditionPublished • loading... • Updated
GLP-1 drugs' heart health benefits not solely from weight loss: study - Health Care Today
Summary by healthcaretoday.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
GLP-1 drugs' heart health benefits not solely from weight loss: study - Health Care Today
As the popularity of GLP-1 receptor agonists for weight loss continues to grow, researchers continue to examine how these medications might impact other areas of a person’s health. In 2023, published research findings reported that semaglutide could potentially reduce a person’s risk for heart attack, stroke, and major cardiac events by 20%. Building off this research, a new study offers further evidence of semaglutide and lowered major cardiac …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
